Ciclosporin/rituximabLack of efficacy and COVID-19: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86939-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：121 / 121

相关论文

共 50 条

[1] Ciclosporin/rituximabLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 138 - 138
[2] Remdesivir/rituximabLack of efficacy and long COVID-19 syndrome: case report
Reactions Weekly, 2023, 1949 (1) : 373 - 373
[3] COVID-19 vaccine/rituximabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 237 - 237
[4] COVID-19 vaccines/rituximabLack of efficacy: 6 case reports
Reactions Weekly, 2021, 1885 (1) : 161 - 161
[5] Ciclosporin/rituximabLack of efficacy in idiopathic focal and segmental glomerulosclerosis: case report
Reactions Weekly, 2020, 1813 (1) : 80 - 80
[6] RituximabLack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 432 - 432
[7] RituximabLack of efficacy: case report
Reactions Weekly, 2023, 1975 (1) : 335 - 335
[8] RituximabLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 446 - 446
[9] RituximabLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 872 - 872
[10] RituximabLack of efficacy: case report
Reactions Weekly, 2023, 1957 (1) : 475 - 475

← 1 2 3 4 5 →